CEL-SCI CORPORATION Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CEL-SCI CORPORATION stock issued during period, value, new issues for the quarter ending 2026-06-30 was $9.70M, a 94.00% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, value, new issues for the quarter ending 2025-06-30 was $5.00M.
- CEL-SCI CORPORATION stock issued during period, value, new issues for the quarter ending 2025-03-31 was $2.56M, a 66.97% decline year-over-year.
- CEL-SCI CORPORATION stock issued during period, value, new issues for the quarter ending 2024-12-31 was $5.00M, a 0.41% increase year-over-year.
- CEL-SCI CORPORATION stock issued during period, value, new issues for fiscal 2025 was $28.29M, a 20.00% increase from fiscal 2024.
- CEL-SCI CORPORATION stock issued during period, value, new issues for fiscal 2024 was $23.57M, a 285.06% increase from fiscal 2023.
- CEL-SCI CORPORATION stock issued during period, value, new issues for fiscal 2023 was $6.12M.
- CEL-SCI CORPORATION stock issued during period, value, new issues for fiscal 2021 was $47.36M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $9.70M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $28.29M 10-K · filed 2025-12-29 | |
| 2025-06-30 | $5.00M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $2.56M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $5.00M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $23.57M 10-K · filed 2025-12-29 | |
| 2024-03-31 | $7.75M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $4.98M 10-Q · filed 2025-08-14 | |
| 2023-09-30 | $6.12M 10-K · filed 2025-01-13 | |
| 2023-06-30 | $1.55M 10-Q · filed 2024-08-14 | |
| 2021-09-30 | $47.36M 10-K · filed 2022-12-27 | |
| 2020-03-31 | $7.87M 10-Q/A · filed 2020-12-30 | |
| 2019-12-31 | $5.05M 10-Q · filed 2021-05-17 | |
| 2018-09-30 | $11.79M 10-K/A · filed 2019-12-23 | |
| 2018-03-31 | $4.67M 10-Q · filed 2019-08-14 | |
| 2017-12-31 | $2.45M 10-Q · filed 2019-08-14 | |
| 2017-09-30 | $10.53M 10-K · filed 2018-12-19 | |
| 2016-09-30 | $21.37M 10-K · filed 2017-12-29 | |
| 2015-09-30 | $21.15M 10-K/A · filed 2017-12-11 | |
| 2014-09-30 | $28.45M 10-K/A · filed 2017-12-11 | |
| 2013-09-30 | $9.79M 10-K · filed 2015-12-11 | |
| 2012-09-30 | $14.29M 10-K · filed 2014-12-23 | |
| 2011-09-30 | $3.94M 10-K · filed 2013-12-27 | |
| 2009-09-30 | $32.24M 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |